Navigation Links
Shareholders Demand Philip Morris USA Stop Interfering in Health Policy
Date:5/28/2008

RICHMOND, Va., May 28 /PRNewswire-USNewswire/ -- At today's Altria (Philip Morris USA) annual meeting, shareholders demanded that the corporation stop lobbying against public health and tobacco control measures. America's largest tobacco corporation is opposing the Smuggled Tobacco Prevention (STOP) Act recently introduced in the U.S. House of Representatives (H.R. 5689), which contains new and stronger requirements on labeling, tracking and reporting by the tobacco industry.

This is the corporation's first annual meeting since it spun off its international tobacco business in March. PM USA executives are predicting that the split will reverse the revenue and operating profits decline of the last seven years.

"While executives continue to calculate how to build new fortunes for Philip Morris USA, our members continue to demand that the corporation stop promoting addictive, deadly products like Marlboro and Virginia Slims to our kids," said Tom Gaffney, spokesperson for Corporate Accountability International in a statement to Altria Chair and CEO Michael Szymanczyk.

On May 31, Gaffney's organization is joining the World Health Organization's (WHO) "World No Tobacco Day," which urges action to reverse a preventable epidemic that kills 5.4 million people each year. This year's event calls for a ban on tobacco advertising, promotion and sponsorship. Such a ban is one of the provisions of the WHO global tobacco treaty that now binds more than 150 countries.

The Bush Administration signed the global tobacco treaty four years ago, during the last U.S. Presidential election campaign, but has yet to submit it to the Senate for ratification.

"Big Tobacco's political influence is the single greatest obstacle to effective tobacco control policy in the U.S. and around the world," said Gaffney.

Prior to its breakup, in 2006 Philip Morris/Altria had three registered lobbyists in Washington for every five U.S. Senators. In the first quarter of this year, the corporation spent $3 million lobbying on a range of public health, tobacco control and regulatory measures.

For more than 15 years, Corporate Accountability International has pressured Big Tobacco to decrease its influence-peddling on Capitol Hill and stop interfering in life-saving policies. And despite its reluctance to do so, what was once the world's largest and most profitable tobacco corporation has changed its name, broken into three pieces, been subject to Congressional hearings, paid out millions in settlements and closed its New York City headquarters.

Corporate Accountability International, formerly Infact, is a membership organization that protects people by waging and winning campaigns challenging irresponsible and dangerous corporate actions around the world. For over 25 years, we've forced corporations -- like Nestle, General Electric and Philip Morris/Altria -- to stop abusive actions. Corporate Accountability International, an NGO in Official Relations with the World Health Organization (WHO), played a key role in development of the FCTC. For more information visit http://www.StopCorporateAbuse.org.

Contact

Sara Joseph, 617-447-2527, SJoseph@StopCorporateAbuse.org

Nick Guroff, 617-447-2507, NGuroff@StopCorporateAbuse.org


'/>"/>
SOURCE Corporate Accountability International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
2. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
3. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
4. United Medicorp, Inc.s Shareholders Approve All Proposals
5. Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
6. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
7. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
8. Flextronics Shareholders and Solectron Stockholders Approve Acquisition
9. Healthcare Technologies to Reschedule the Shareholders Meeting to Approve the NexGen Biofuels Transaction
10. Lafley Tells Shareholders That P&G is Designed to Grow
11. Manor Care Shareholders Vote to Approve $6.3 Billion Carlyle Buyout
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: